The raised guidance signals accelerating margin improvement and profitability, which should drive positive sentiment. Monitor the Investor Day webcast for additional strategic targets and any commentary on membership growth or 2027 outlook that could further move the stock.
Price Chart
Executive Summary
Oscar Health raised its full-year 2026 guidance at its Investor Day, improving the Medical Loss Ratio outlook by 50 bps to 81.0%-82.0% and increasing Earnings from Operations guidance by $100M to $600M-$800M, while reaffirming revenue of $18.7B-$19.0B. This is a clear positive operational signal, indicating better-than-expected underwriting performance and profitability trajectory for the year.
Key Facts
- Raised FY 2026 Medical Loss Ratio guidance to 81.0%-82.0%, a 50 bps improvement from prior 81.5%-82.5%
- Raised FY 2026 Earnings from Operations guidance to $600M-$800M, a $100M increase from prior $500M-$700M
- Reaffirmed FY 2026 Total Revenue guidance of $18.7B-$19.0B
- Reaffirmed FY 2026 SG&A Expense Ratio guidance of 15.6%-16.1%
- Filed as Item 7.01 Regulation FD Disclosure in conjunction with 2026 Investor Day
Financial Impact
Earnings from Operations guidance raised by $100M to a midpoint of $700M; Medical Loss Ratio improved by 50 bps to a midpoint of 81.5%
Risk Factors
- Guidance is forward-looking and subject to medical cost trends and utilization volatility
- Revenue guidance unchanged at $18.7B-$19.0B, so top-line growth is not accelerating
- Historical calibration shows score-7 filings in this segment have only a 43-44% observed probability of up-moves at T+20, suggesting elevated uncertainty despite the positive news
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001568651-26-000074 |
| Document: 0001568651-26-000074-index-headers.html | 0001568651-26-000074 |
| Document: 0001568651-26-000074-index.html | 0001568651-26-000074 |
| Document: 0001568651-26-000074.txt | 0001568651-26-000074 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 16d ago | 8-K | $32.34 $31.29 | ▼ −3.25% | ▼ −6.08% | $30.94 (−4.33%) |
Aug 18, 2026 6w ago | 144 | $32.30 $31.24 | ▲ +3.28% | ▲ +2.89% | $30.94 (+4.21%) |
Aug 10, 2026 7w ago | 144 | $27.97 $31.28 | ▲ +11.83% | ▲ +12.24% | $30.94 (+10.62%) |
Jul 6, 2026 12w ago | Insider Cluster | $31.44 $30.54 | ▲ +2.86% | ▲ +3.35% | $30.94 (+1.59%) |
Jul 1, 2026 13w ago | Insider Cluster | $31.90 $31.12 | ▲ +2.45% | ▲ +2.71% | $30.94 (+3.01%) |
Jun 11, 2026 16w ago | Institutional Cluster | $28.91 $28.27 | ▼ −2.21% | ▼ −2.65% | $30.94 (+7.02%) |
Jun 8, 2026 16w ago | 8-K | $27.39 $29.14 | ▲ +6.39% | ▲ +4.28% | $30.94 (+12.96%) |
Jun 4, 2026 17w ago | Insider Cluster | $24.51 $28.26 | ▲ +15.30% | ▲ +14.73% | $30.94 (+26.23%) |
Jun 2, 2026 17w ago | 144 | $20.50 $27.85 | ▼ −35.85% | ▼ −39.67% | $30.94 (−50.93%) |
Jun 2, 2026 17w ago | 8-K | $21.14 $27.22 | ▲ +28.76% | ▲ +31.73% | $30.94 (+46.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access